Literature DB >> 8706580

[Comparison of simple methods to screen predisposing eye of primary angle-closure glaucoma].

T Ye1, W Mao, D Lu.   

Abstract

6,584 population over 40 years old in Canton universities and factories were screened for the predisposing eyes of primary angle-closure glaucoma (PACG). In the screening, three methods for the measurement of anterior chamber depth were used and compared and the critical limits of two simple ones of them [peripheral anterior chamber depth (PACD) and oblique illumination test with a flashlight] were evaluated. It was found that the incidence of PACG is as high as 10.0% in eyes with axial anterior chamber depth (AACD) < or = 2.0 mm, it is 6.7% in eyes with peripheral anterior chamber depth (PACD) < or = 1/4 corneal thickness (CT) and is 6.9% in eyes with iris light band ratio (ILBR) < or = 1/4. Also, we found that the incidence of PACG is as high as 77.8% in eyes with AACD < or = 1.6 mm and 100.0% in, AACD < or = 1.4 mm. The authors propose that PACD < or = 1/4 CT and ILBR < or = 1/4 can be the critical values of the two methods for the primary step of PACG screening.

Entities:  

Mesh:

Year:  1995        PMID: 8706580

Source DB:  PubMed          Journal:  Zhonghua Yan Ke Za Zhi        ISSN: 0412-4081


  3 in total

1.  Ability of non-ophthalmologist doctors to detect eyes with occludable angles using the flashlight test.

Authors:  Carolina Pelegrini Barbosa Gracitelli; Bruno Landgren; Flávia Bracale Graciani; Aline Kátia Siqueira Sousa; Augusto Paranhos; Tiago Santos Prata
Journal:  Int Ophthalmol       Date:  2013-10-01       Impact factor: 2.031

2.  Anterior chamber depth measured by two methods in myopic and hyperopic phakic IOL implant.

Authors:  M Vetrugno; N Cardascia; L Cardia
Journal:  Br J Ophthalmol       Date:  2000-10       Impact factor: 4.638

3.  Non-contact tests for identifying people at risk of primary angle closure glaucoma.

Authors:  Anish Jindal; Irene Ctori; Gianni Virgili; Ersilia Lucenteforte; John G Lawrenson
Journal:  Cochrane Database Syst Rev       Date:  2020-05-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.